Keystone Symposia aims to advance life science discovery through exchange and dialogue among a diverse community
of scientists participating in our high-quality research conferences throughout the world. In this spirit, all
Keystone Symposia events are open to all, and the organization strives for an inclusive and welcoming environment.
We highly value diversity of opinions and experiences at our conferences and in the scientific community.
The participation of scientists from ALL countries and backgrounds is extremely important to our organization.
The recent White House Executive Order could potentially restrict the scientific diversity at Keystone Symposia
conferences, thereby diminishing the excellence of our meetings, thwarting efforts toward inclusion of all attendees
and discouraging collaboration among different scientific cultures that is vital to the advancement of science.
At Keystone Symposia, we remain committed to these principles. We are therefore working on behalf of all those
who wish to attend Keystone Symposia conferences to ensure that they receive the attention needed to facilitate
their attendance within the boundaries of the law in this very fluid situation.
We are aware that this Executive Order, if reinstated, may impact not just scientists, students and postdoctoral
fellows who are nationals of the affected nations, and living in those countries, but also nationals of those
countries who are now working or studying elsewhere. Reinstatement may also result in changes in the visa
issuance process that could delay approval of visas required for nationals from certain countries who wish
to attend our conferences. Anyone affected who has submitted an abstract or registered for one of our upcoming
conferences but who may no longer be able to attend the conference due to the Executive Order should not hesitate
to contact our Attendee Services Department (+1 800-253-0685; +1 970-262-1230; email@example.com)
Keystone Symposia Expands Global Health Conference Series in Support of International Efforts to Combat Infectious Diseases
Bill & Melinda Gates Foundation Supports Series with Grant of $2.5 million
SILVERTHORNE, Colo. - October 10, 2006 - Keystone Symposia on Molecular and Cellular Biology has received a 3- year grant of $2,599,679 to support an expansion of Keystone Symposia's Global Health Series. For 35 years, Keystone Symposia has been internationally recognized for presenting scientific conferences focused on topics at the leading edge of current biomedical research and featuring the worlds most respected and productive research scientists. Keystone Symposia holds approximately 55 scientific meetings each year; about 15% are focused on specific infectious diseases which affect the developing world. The mission of the Symposia is to benefit society by serving as a catalyst for the advancement of biomedical and life sciences.
In addition to Keystone Symposia's regularly scheduled infectious disease meetings, the Bill & Melinda Gates Foundation grant will support an annual Keystone Symposia conference to be held immediately before or after the Grand Challenges in Global Health annual meeting. The first of these meetings: Challenges of Global Vaccine Development will be held October 8-13, 2007 in Cape Town, South Africa and involve about 300 scientists including many of the Grand Challenges in Global Health investigators. These 46 scientists received a total of $436.6 million from the Bill & Melinda Gates Foundation for a broad range of innovative research projects aimed at achieving scientific breakthroughs against diseases that kill millions of people each year in the world's poorest countries.
The scientific organizers of Challenges of Global Vaccine Development meeting are Margaret Liu M.D., Ph.D, ProTherImmune and Visiting Professor, Karolinska Institute, Paul-Henri Lambert M.D., Professor, University of Geneva, and Sir Gustav Nossal, M.D., Ph.D., University of Melbourne. This meeting will bring together scientists, physicians and students from the developed and developing world to discuss recent scientific advances and the remaining challenges in developing and administering vaccines for a variety of diseases. As well as discussing recent immunological discoveries at the molecular and cellular level, scientists will review advances in new immunization technologies, including those useful in developing nations, the unique requirements of early childhood vaccines, and ways to determine safety and efficacy prior to testing new vaccines in human populations. The Bill & Melinda Gates Foundation grant will help cover meeting costs, but most importantly will provide a variety of scholarships and travel awards for scientists from the developing world, especially students and post-doctoral fellows from the African continent.
Tadataka Yamada M.D., President, Global Health, Bill & Melinda Gates Foundation applauds Keystone Symposia's mission to connect biomedical scientists and encourage sharing and collaboration. "We're trying to deal with very difficult problems that people are suffering from in the developing world," he said. "The more information sharing there is, the more patients will benefit. The Keystone meetings are some of the best venues for forming collaborations and helping science to move forward toward solutions for health problems."
Other meetings planned for 2007, and supported by the Bill & Melinda Gates Foundation grant include: Drugs against Protozoan Parasites, Immunologic Memory, Tuberculosis: From Lab Research to Field, Molecular and Cellular Determinants of HIV Pathogenesis, HIV Vaccines: From Basic Research to Clinical Trials. Approximately 1,450 scientists from around the world are expected to attend these 5 meetings. The Bill & Melinda Gates Foundation grant will help cover some meeting costs, but again, most importantly will provide a variety of scholarships and travel awards for scientists, physicians, and students from the developing world, especially from those nations where these diseases are endemic and result in millions of needless deaths.
Keystone Symposia CEO and former pharmaceutical executive, Dr. James W. Aiken expressed the Symposia's gratitude for this valuable assistance from the Bill & Melinda Gates Foundation grant. "We are tremendously pleased to be partnering with the Bill & Melinda Gates Foundation in this important project. The goals of the Gates Foundation and Keystone Symposia's objective to accelerate the pace of discovery by catalyzing global sharing of knowledge are well aligned. Breakthroughs in scientific thinking happen most often when groups of scientists from diverse backgrounds have the opportunity to talk together about their work, and to both encourage and challenge each other. Keystone Symposia has a long and proven record of providing an environment which fosters meaningful interaction and promotes collaborations between both experienced and junior scientists, as well as between academic, government, clinical, and industry investigators. We look forward to bringing together some of the world's most innovative and productive scientists, who are dedicated to saving and improving the lives of children and adults who are affected by these infectious diseases."
Infectious diseases have long been an important part of Keystone Symposia's annual series. Meetings on Viral Research and Mechanisms of Viral Disease were held in 1973 and 1974, and the first conference on Acquired Immune Deficiency Syndrome (AIDS) was held in February of 1984, more than a year before the 1st International Conference on AIDS. Keystone Symposia's annual meetings on HIV pathology and HIV vaccines are reputed to be the best scientific meetings in the world on these topics.
About Keystone Symposia
Keystone Symposia on Molecular and Cellular Biology has been holding internationally renowned scientific meetings since 1972, and has been headquartered in Summit County, Colorado since 1990, when the organization left the University of California at Los Angeles. Annually, Keystone Symposia holds between 45 and 55 meetings, involving more than 13,000 scientists from around the world. Most of the meetings are held in the Rocky Mountain U.S. states and Canadian provinces, with a few each year now scheduled for Asia, Africa, and Europe.